Johnson & Johnson will not be undertaking local trials for its single-shot COVID-19 vaccine in India.
That's according to a report in The Economic Times on Tuesday, citing a company spokesperson.
While J&J had sought approval for conducting bridging trials in the country, the US-based drugmaker said it wouldn't have to do that now since India has scrapped that requirement,
The company is exploring how to accelerate the availability of its vaccine in India, the newspaper added.
Kuwait intercepts missile, drone attacks, Bahrain activates siren
Kuwaiti has faced another round of missile and drone attacks late on Tuesday, while Bahrain announced that a warning siren had been sounded across the country.
US to re-engage with Gavi vaccine alliance amid Ebola outbreak
US Secretary of State Marco Rubio said on Tuesday that the US would re-engage with the global vaccine alliance Gavi amid the Ebola outbreak in several African countries.
Bolivia's defence minister resigns as anti-government protests intensify
Bolivia's defence minister has stepped down on Tuesday after a month of anti-government protests, two government sources said, marking the highest-level departure yet under centrist President Rodrigo Paz who is himself facing calls to resign.
Iran studying deal to halt war as stalemate persists
Iran is reviewing a proposed agreement with the United States to halt the war between the two countries, Iran's Mehr news reported on Tuesday, after US President Donald Trump said talks to reach a deal were continuing.
WHO says suspected Ebola cases drop to 116 after hundreds ruled out
The World Health Organisation said there have been 321 confirmed cases of Ebola in the Democratic Republic of Congo outbreak and 116 suspected cases, marking a large drop in the number of suspected cases as hundreds were ruled out after investigation.
